[PTGX] YoY Quarter Result on 31-Dec-2016 [#Q4]

Stock
[PTGX] Protagonist Therapeutics, Inc.
Announcement Date
07-Mar-2017
Financial Year
2016
Quarter
31-Dec-2016 [#Q4]
Profit Trend
QoQ- -58.78%
YoY- -104.77%
Quarter Report
PTGX's Result
PTGX's Financial Summary
View:
Show?
Quarter Result
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Revenue 8,617 5,650 2,719 2,353 11,282 0 0 -
PBT -36,907 -18,886 -16,645 -14,664 -3,052 -11,248 -5,493 37.32%
Tax -832 -1,305 856 -799 -117 -75 492 -
NP -36,907 -18,886 -17,501 -13,865 -3,052 -11,248 -5,493 37.32%
Tax Rate - - - - - - - -
Total Cost 45,524 24,536 20,220 16,218 14,334 11,248 5,493 42.21%
Ratio Analysis
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
NP Margin -428.30 -334.27 -643.66 -589.25 -27.05 0.00 0.00 -
Per Share
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
EPS -0.77 -0.48 -0.63 -0.57 -0.15 -0.67 -0.93 -3.09%
EPS Diluted -0.77 -0.48 -0.63 -0.57 -0.15 -0.67 -0.93 -3.09%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.